Royalty Pharma
RPRX | NASDAQ
$58.46
+$0.02 (+0.03%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 618.7M | 929.03M | 477.01M | 1.71B | 1.54B | 1.01B |
Short-Term Investments | 18.8M | 841.97M | 756.74M | 717.04M | 1.26B | 1.64B |
Long-Term Investments | 171.31M | 16.39B | 15.1B | 14.23B | 14.63B | 13.28B |
Other Long-Term Assets | 15.97B | -15.09B | 6.52M | 29.63M | 4.15M | 10M |
Receivables | 883.7M | 26.96M | 22.41M | 36.6M | 68.31M | 39.17M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | -902.2M | 4.19M | 18.04M | 90.52M | 6.63M | 8.6M |
Total Current Assets | 619M | 1.8B | 1.27B | 2.55B | 2.88B | 2.7B |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 924.63M | 15.13B | n/a | n/a | 5.67M | 28.67M |
Total Long-Term Assets | 17.06B | 16.42B | 15.11B | 14.26B | 14.64B | 13.32B |
Total Assets | 19.62B | 18.22B | 16.38B | 16.81B | 17.52B | 16.02B |
Account Payables | 19.4M | 13.37M | 15.17M | 7.91M | 5.62M | 10.78M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 380M | 997.77M | n/a | 997.51M | n/a | n/a |
Other Current Liabilities | 163.98M | 68.6M | 11.38M | 12.4M | n/a | 18.6M |
Total Current Liabilities | 636.21M | 1.25B | 161.38M | 1.17B | 171.25M | 307.89M |
Long-Term Debt | 8.57B | 6.61B | 6.14B | 6.12B | 7.1B | 5.82B |
Other Long-Term Liabilities | 682.61M | 12.08M | 900K | 2.5M | n/a | n/a |
Total Long-Term Liabilities | 9.27B | 6.63B | 6.14B | 6.12B | 7.1B | 5.82B |
Total Liabilities | 9.91B | 7.88B | 6.3B | 7.29B | 7.27B | 6.12B |
Total Debt | 8.95B | 7.61B | 6.14B | 7.12B | 7.1B | 5.82B |
Book Value | 9.71B | 10.34B | 10.08B | 9.53B | 10.25B | 9.9B |
Book Value Per Share | 17.36 | 17.41 | 16.73 | 16.86 | 24.71 | 25.50 |
Common Stock | 106K | 108K | 108K | 107K | 106K | 102K |
Retained Earnings | 2.36B | 2.85B | 2.52B | 1.96B | 2.26B | 1.92B |
Comprehensive Income | n/a | n/a | n/a | n/a | 16.49M | 34.4M |
Shareholders Equity | 6.48B | 6.95B | 6.53B | 5.63B | 5.78B | 4.82B |
Total Investments | 190.11M | 17.23B | 15.86B | 14.95B | 15.89B | 14.93B |
Add to Watchlist
Select watchlists to add or remove RPRX